Capricor Therapeutics Inc (CAPR) — Cash Flow Reinvestment Rate
Capricor Therapeutics Inc (CAPR) has a Cash Flow Reinvestment Rate of 0.76x as of March 2023, reinvesting $3.21 Million (capex $453.12K plus investments $-2.76 Million) from operating cash flow of $4.21 Million. Check Capricor Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Capricor Therapeutics Inc Cash Flow Reinvestment Rate (2014–2022)
Historical reinvestment intensity for Capricor Therapeutics Inc across 2 annual periods. Explore Capricor Therapeutics Inc (CAPR) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Capricor Therapeutics Inc (2014–2022)
Year-by-year capital reinvestment analysis for Capricor Therapeutics Inc. For live market cap and broader valuation context, see market value of Capricor Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 7.13x | $35.07 Million | $4.92 Million | $3.36 Million | ▲ +1230.6% |
| 2014 | 0.54x | $513.90K | $958.56K | $186.43K | — |